2011
DOI: 10.1007/s12038-011-9151-9
|View full text |Cite
|
Sign up to set email alerts
|

Fibrinolysis and anticoagulant potential of a metallo protease produced by Bacillus subtilis K42

Abstract: In this study, a potent fibrinolytic enzyme-producing bacterium was isolated from soybean flour and identified as Bacillus subtilis K42 and assayed in vitro for its thrombolytic potential. The molecular weight of the purified enzyme was 20.5 kDa and purification increased its specific activity 390-fold with a recovery of 14%. Maximal activity was attained at a temperature of 40 degree C (stable up to 65 degree C) and pH of 9.4 (range: 6.5 - 10.5). The enzyme retained up to 80% of its original activity after pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(18 citation statements)
references
References 16 publications
0
17
0
1
Order By: Relevance
“…EMB9 [74], and B. circulans M34 [75] produced organic solvent solution-tolerant proteases. Fibrinolytic protease by Bacillus subtilis K42 [76] and Serratia sp. [33] sustained 80-85% of its activity in the presence of organic solvents.…”
Section: Effect Of Inhibitors/activators Metal Ions and Organic Solmentioning
confidence: 99%
“…EMB9 [74], and B. circulans M34 [75] produced organic solvent solution-tolerant proteases. Fibrinolytic protease by Bacillus subtilis K42 [76] and Serratia sp. [33] sustained 80-85% of its activity in the presence of organic solvents.…”
Section: Effect Of Inhibitors/activators Metal Ions and Organic Solmentioning
confidence: 99%
“…Aprotinin, a serine protease inhibitor (Yin et al, 2010;Park et al, 2012b) (5 mg mL À1 in sterile water, Sigma), was added to the azocasein assay mixture. Similarily, iodoacetamide (100 mM, Sigma) and EDTA (100 mM, Sigma) were added in the azocasein assay as cysteine and metalloprotease inhibitors (Jankiewicz & Bielawski, 2002;Keller et al, 2004;Yin et al, 2010;Hassanein et al, 2011), respectively. The assay consisted of 400 lL azocasein, 500 lL S. epidermidis SN and 300 lL inhibitor.…”
Section: Effect Of S Epidermidis Sn On S Aureus Biofilmsmentioning
confidence: 99%
“…-: S. epidermidis was not isolated from that sample. EDTA are used as cysteine and metalloprotease inhibitors, respectively (Jankiewicz & Bielawski, 2002;Keller et al, 2004;Yin et al, 2010;Hassanein et al, 2011). Adding aprotinin and iodoacetamide to the azocasein assay significantly (P < 0.05) reduced the protease activity, indicating that both serine and cysteine proteases are produced by the S. epidermidis isolates.…”
Section: Effectmentioning
confidence: 99%
“…Комплексні ферментні препарати з такою специфічністю можуть бути використані в різ них галузях медицини та промисловості. Протеолітичні ферменти з фібринолітичною і коагулазною дією можуть деякою мірою вирішити проблему створення тромболітичних препаратів [9]. Протеолітичні ферменти з колагеназною активністю використовуються у виробництві шкіри, для дезінтеграції сполучної тканини, отримання суспензії клітин або клітинних новоутворень, оскільки при збереженні життєздатності клітини необхідне вибіркове руйнування позаклітинного матриксу без ушкодження поверхні живих клітин [18].…”
Section: проведено скринінг продуцентів протеаз із специфічністю до нunclassified